The novel truncated frameshift mutations at the GLTSCR1 microsatellite site result in the loss of the antimetastatic roles of GLTSCR1 in CRC, which might decrease the sensitivity of CRC cells to BET inhibitors. The gene discussed is DNER; the disease is colorectal carcinoma.